About
Technology
Issues
FAQ
Links
Official Page
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.